← 返回

睾丸生殖细胞肿瘤中 KLRB1 表达及其临床意义的综合分析:一篇综述

英文原题:A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.

查看英文原题

A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.

PubMed 2024/04/12(内容时间) Medicine (Baltimore) Q2 · IF 2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

睾丸生殖细胞肿瘤(TGCT)是最常见的睾丸恶性肿瘤。KLRB1被认为影响多种癌症的发生和进展。然而,KLRB1基因在TGCT中的作用尚不清楚。首先,利用癌症基因组图谱(TCGA)数据集和GTEx(基因型-组织表达)数据集确定了KLRB1在TGCT中的表达水平。利用TCGA数据集探讨了KLRB1的临床意义和生物学功能,并使用基因集变异分析和TIMER数据库分析了KLRB1基因与肿瘤免疫及浸润免疫细胞的相关性。我们发现,以相应的正常组织为对照,KLRB1在TGCT恶性组织中的表达水平上调,且KLRB1表达与TGCT的临床病理特征相关。功能富集分析提示KLRB1可能参与免疫反应和炎症反应。KLRB1与免疫反应中NK 细胞活化高度正相关,并与肿瘤浸润免疫细胞正相关。本研究首次证明了KLRB1在TGCT中的作用,其可能作为一种与免疫浸润相关的新生物标志物,并为TGCT的治疗提供潜在的治疗靶点。

展开英文摘要原文

Testicular germ cell tumors (TGCT) are the most common testicular malignancies. KLRB1 is considered to influence the development and progression of a number of cancers.

However, it is unclear how the KLRB1 gene functions in TGCT. First, it was determined the expression level of KLRB1 in TGCT using The Cancer Genome Atlas (TCGA) (The Cancer Genome Atlas) dataset and GTEx (Genotype-Tissue Expression) dataset. The clinical significance and biological functions of KLRB1 were explored using the TCGA dataset, and we analyzed the correlation of the KLRB1 gene with tumor immunity and infiltrating immune cells using gene set variation analysis and the TIMER database.

We found that the expression level of KLRB1 was upregulated in TGCT malignant tissues with the corresponding normal tissues as controls, and KLRB1 expression correlated with clinicopathologic features of TGCT. Functional enrichment analysis suggested that KLRB1 might be involved in immune response and inflammatory response. KLRB1 was highly positively correlated with natural killer cell activation in immune response and positively correlated with tumor-infiltrating immune cells.

This study demonstrated for the first time the role of KLRB1 in TGCT, which may serve as a new biomarker associated with immune infiltration and provide a potential therapeutic target for the treatment of TGCT.

论文信息

作者
Li L、Hu Y、Li X、Ju B
第一作者单位
The First Clinical School of Medicine Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.China
通讯作者单位
Department of Andrology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.China
文献类型
综述
期刊
Medicine2024 Apr 12
原文标识
PubMed 38608099 · DOI 10.1097/MD.0000000000037688